Skip to main content

UBS Group AG

Position in CMMB — Chemomab Therapeutics Ltd.

CIK 1610520 ZURICH, V8

Position in CMMB

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$12
-$3,705 QoQ
Shares Held
8
-99.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2021
17 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CMMB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,675,801 across 560 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in CMMB

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $12 8
2025-12-31 $3,717 2,253
2025-09-30 $260 99
2025-06-30 $460 397
2025-03-31 $962 883
2024-12-31 $877 485
2024-09-30 $3,592 2,288
2023-09-30 $126 141
2023-06-30 $15 12
2023-03-31 $653 411
2022-12-31 $14,812 4,629
2022-09-30 $12,171 4,888
2022-03-31 $4,248 885
2021-12-31 $12,730 1,845
2021-09-30 $19,400 1,751
2021-06-30 $2,643 139
2021-03-31 $23,944 834